Try our Advanced Search for more refined results

Mylan Facing Antitrust Probe Over EpiPen's Market Power

By Bonnie Eslinger (January 30, 2017, 10:04 PM EST) -- Mylan NV confirmed Monday that it was under investigation by the Federal Trade Commission for practices related to sales of its EpiPen allergy emergency treatment, but said any suggestion the company took "inappropriate or unlawful actions to prevent generic competition is without merit."...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!